Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...
What happens when multiple AI agents work together to solve complex problems? In this video, we dive into multi-agent systems ...
There are stark socioeconomic and ethnic inequalities in babies admitted to and who die in neonatal units in England and ...